TPES: tumor purity estimation from SNVs

Bioinformatics. 2019 Nov 1;35(21):4433-4435. doi: 10.1093/bioinformatics/btz406.

Abstract

Motivation: Tumor purity (TP) is the proportion of cancer cells in a tumor sample. TP impacts on the accurate assessment of molecular and genomics features as assayed with NGS approaches. State-of-the-art tools mainly rely on somatic copy-number alterations (SCNA) to quantify TP and therefore fail when a tumor genome is nearly euploid, i.e. 'non-aberrant' in terms of identifiable SCNAs.

Results: We introduce a computational method, tumor purity estimation from single-nucleotide variants (SNVs), which derives TP from the allelic fraction distribution of SNVs. On more than 7800 whole-exome sequencing data of TCGA tumor samples, it showed high concordance with a range of TP tools (Spearman's correlation between 0.68 and 0.82; >9 SNVs) and rescued TP estimates of 1, 194 samples (15%) pan-cancer.

Availability and implementation: TPES is available as an R package on CRAN and at https://bitbucket.org/l0ka/tpes.git.

Supplementary information: Supplementary data are available at Bioinformatics online.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA Copy Number Variations
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Neoplasms*
  • Nucleotides
  • Software

Substances

  • Nucleotides